SCHEMBL2275459

SCHEMBL2275459

O=C(Nc1cc(-c2cc3ccccc3o2)ccc1C(=O)O)c1ccc2c(c1)OCO2

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.58
KDM4E B2RXH2 8/20 0.58
HPGD P15428 6/20 0.58
ALDH1A1 P00352 6/20 0.58
HSD17B10 Q99714 5/20 0.58
KMT2A Q03164 5/20 0.58
NPSR1 Q6W5P4 4/20 0.58
HTT P42858 4/20 0.58
TSHR P16473 3/20 0.58
TP53 P04637 2/20 0.58
SAE1 Q9UBE0 1/20 0.58
UBA2 Q9UBT2 1/20 0.58
HDAC2 Q92769 1/20 0.56
ALOX15 P16050 1/20 0.56
PTGS2 P35354 1/20 0.55
MAPT P10636 7/20 0.52
LMNA P02545 2/20 0.52
RAB9A P51151 7/20 0.51
SMN1; SMN2 Q16637 5/20 0.51
PKM P14618 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2274808 0.85 HDAC2 (0.74) NPC1KDM4EALDH1A1KMT2AHDAC2
SCHEMBL2273182 0.84 PTGS2 (0.66) NPC1KDM4EHPGDALDH1A1HSD17B10
SCHEMBL2272541 0.83 PTGS2 (0.63) NPC1KDM4EHPGDALDH1A1HSD17B10
SCHEMBL2269533 0.83 HDAC2 (0.64) NPC1KDM4EALDH1A1KMT2AHTT
SCHEMBL2274783 0.81 HDAC2 (0.62) NPC1KDM4EALDH1A1KMT2ATP53
SCHEMBL2274795 0.80 NPC1 (0.60) NPC1KDM4EHPGDALDH1A1HSD17B10
SCHEMBL2272018 0.79 HDAC2 (0.62) NPC1HPGDKMT2AHTTHDAC2
SCHEMBL2277756 0.79 PTGS2 (0.57) NPC1KDM4EHPGDALDH1A1HSD17B10
SCHEMBL5145182 0.78 NPC1 (0.61) NPC1KDM4EHPGDALDH1A1HSD17B10
SCHEMBL2274216 0.78 RAB9A (0.60) NPC1KDM4EHPGDALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
EP-1820795-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP26, MMP11 NPC1 4836/4885KDM4E 1257/4885HPGD 274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.